Amedisys Inc (AMED)
Return on assets (ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -9,747 | 118,609 | 209,072 | 183,608 | 126,833 |
| Total assets | US$ in thousands | 2,060,170 | 1,976,240 | 1,856,970 | 1,567,200 | 1,262,740 |
| ROA | -0.47% | 6.00% | 11.26% | 11.72% | 10.04% |
December 31, 2023 calculation
ROA = Net income ÷ Total assets
= $-9,747K ÷ $2,060,170K
= -0.47%
Amedisys Inc.'s return on assets (ROA) has displayed a downward trend over the five-year period from 2019 to 2023. In 2019, the company achieved an ROA of 10.04%, which increased to 11.72% in 2020 and then to 11.26% in 2021. However, the trend reversed in the following years, with ROA dropping significantly to 6.00% in 2022 and further deteriorating to -0.47% in 2023.
The negative ROA in 2023 indicates that Amedisys Inc. experienced a loss on its assets during that year. This decline is concerning as it suggests that the company may be facing challenges in generating profits relative to its total assets. It could be attributed to various factors such as increased expenses, lower revenue, or impairment charges on assets.
Overall, the fluctuating ROA of Amedisys Inc. suggests that the company's efficiency in utilizing its assets to generate profits has been inconsistent in recent years. Further analysis and investigation into the underlying causes of these fluctuations may be necessary to understand the company's financial performance better.
Peer comparison
Dec 31, 2023